You are about to be taken to a third-party site. The content on this site is for informational use only. Immunocine does not endorse any of the information, products, or services on third-party sites, and no information on third-party sites should be construed as an endorsement or recommendation of specific Immunocine products. By clicking on the link below, you consent to be directed to external material.Proceed Cancel
Head and Neck Cell Cancers (HNC) includes cancers within the oral cavity, sinonasal cavities, pharynx and larynx. HNC is the 6th most common cancer in the world with roughly 550,000 diagnoses each year. Unfortunately, this frequently encountered cancer has a relatively high mortality rate and poor side effect profile associated with common treatments1.
While all cancer types at some level avoid detection by the Immune System, HNC excels at hiding2. HNC’s consistent ability to do so has been of great interest within Cancer Immunotherapy research. Fortunately, researchers have recently uncovered what they believe is the secret weapon of Head and Neck Cancers.
As with any mutated cell in the body, the Immune System is responsible for detecting the mutations and eliminating the cell. This can be divided into three phases:
To see this in action, see below!
However, if the Immune System fails to detect the mutated cell, that single cell can rapidly grow and eventually turn into deadly tumors. And as mentioned above, Head and Neck Cancers are particularly adept at avoiding detection.
Fortunately, the basis of Head and Neck Cancer’s superior ability appears to be finally known. Recent studies have identified that many HNCs secrete “Extracellular Vesicles” (or EVs) which are able to promote tumor survival and growth via a number of different mechanisms3.
One these mechanisms is Head and Neck Cancer’s ability to prevent localized Dendritic Cells from maturing and therefore preventing an immune attack4,5. This is particularly bad news.
Oncology research has repeatedly demonstrated that disruptions in Dendritic Cell activity is one of the most effective strategies for tumors to avoid destruction and continue progression6,7.
Fortunately, Dendritic Cell Treatments that properly activate Dendritic Cells to attack Head and Neck Cancers can overcome this issue. To empower an HNC-targeted Immune Response, the Dendritic Cells need to be:
While this is simple list, Immunocine provides the only Dendritic Cell Treatment that accomplishes all three. Backed by peer-reviewed scientific publications, clinical trials, and patents, Immunocine’s cancer treatment unique process explains why our team has seen success in HNC patients, where other Immunotherapies have not.
To learn how Immunocine does this, we recommend reading this next!
If you or someone you know is currently dealing with an HNC diagnosis, contact us here to begin the process of outsmarting the tumor, launching an HNC-targeted immune response, and taking back control.
*Outside of cancer, the term Antigen can be used to describe any foreign molecules that would trigger an immune response. The Immunocine Science Team did not want to upset any of our fellow immunologists!
May 16, 2023
March 15, 2023
March 12, 2023